Turning Point Therapeutics Inc (TPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TPTX | MDGL | CRNX | ||
| Company | Turning Point Therapeutics Inc | Madrigal Pharmaceuticals Inc | Crinetics Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 75.99 | 192.49 | 42.49 | ||
| High | 76.01 | 195.58 | 42.87 | ||
| Low | 75.98 | 189.00 | 41.66 | ||
| Last | 76.01 | 193.33 | 42.12 | ||
| Change | +0.52 | -1.05 | -0.17 | ||
| % Change | +0.69% | -0.54% | -0.40% | ||
| Volume | 2,843,300 | 453,300 | 563,200 | ||
| 20-Day Average Volume | 962,475 | 410,000 | 787,730 | ||
| Previous Close | 75.49 | 194.38 | 42.29 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 75.11 | 230.29 | 44.94 | ||
| 20-Day Raw Stochastic | 100.00% | 5.48% | 12.54% | ||
| 20-Day Relative Strength | 74.20% | 34.96% | 47.14% | ||
| Weighted Alpha | -18.70 | -39.70 | +39.00 | ||
| Today's Opinion | 96% Buy | 24% Sell | 56% Buy | ||
| Previous Opinion | 96% Buy | 8% Sell | 64% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.29% since 08/09/22 | -8.82% since 04/19/24 | -1.98% since 04/19/24 | ||
| Low | 74.86 on 08/10/22 | 189.00 on 04/26/24 | 41.05 on 04/25/24 | ||
| High | 76.01 on 08/16/22 | 225.66 on 04/23/24 | 45.26 on 04/24/24 | ||
| 1-Month | |||||
| %Chg | +1.82% since 07/15/22 | -21.92% since 03/26/24 | -2.88% since 03/26/24 | ||
| Low | 74.57 on 07/21/22 | 189.00 on 04/26/24 | 41.05 on 04/25/24 | ||
| High | 76.01 on 08/16/22 | 268.22 on 03/28/24 | 49.58 on 04/04/24 | ||
| 3-Month | |||||
| %Chg | +134.02% since 05/16/22 | -14.44% since 01/26/24 | +13.29% since 01/26/24 | ||
| Low | 30.85 on 05/25/22 | 168.25 on 02/09/24 | 35.70 on 02/02/24 | ||
| High | 76.01 on 08/16/22 | 299.98 on 03/15/24 | 49.58 on 04/04/24 | ||
| 6-Month | |||||
| %Chg | +124.48% since 02/16/22 | +54.78% since 10/26/23 | +44.15% since 10/26/23 | ||
| Low | 23.77 on 03/15/22 | 119.76 on 10/27/23 | 25.75 on 11/10/23 | ||
| High | 76.01 on 08/16/22 | 299.98 on 03/15/24 | 49.58 on 04/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,806,125 | 3,846,685 | 2,931,552 | ||
| Shares Outstanding, K | 50,074 | 19,897 | 69,600 | ||
| Annual Sales | 30,830,000 | 0 | 4,010,000 | ||
| Annual Net Income | -236,550,000 | -373,630,000 | -214,530,000 | ||
| Last Quarter Sales | 120,000 | 0 | 350,000 | ||
| Last Quarter Net Income | -123,090,000 | -112,190,000 | -57,460,000 | ||
| 60-Month Beta | -0.18 | -0.47 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.48 on 08/08/22 | -5.68 on 02/28/24 | -0.90 on 02/28/24 | ||
| Latest Earnings Date | 08/08/22 | 05/07/24 | 05/02/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||